SCHEMBL6101212

SCHEMBL6101212

NC(=O)Cc1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 6/20 0.70
PLA2G2A P14555 6/20 0.70
MEN1 O00255 2/20 0.70
KMT2A Q03164 2/20 0.70
HSP90AA1 P07900 1/20 0.70
HSP90AB1 P08238 1/20 0.70
TRPM8 Q7Z2W7 3/20 0.68
KDM4E B2RXH2 1/20 0.68
MAPT P10636 1/20 0.68
ICMT O60725 2/20 0.64
HTR1D P28221 5/20 0.61
POLB P06746 1/20 0.60
PPARG P37231 1/20 0.60
PPARD Q03181 1/20 0.60
PPARA Q07869 1/20 0.60
SLC6A4 P31645 1/20 0.58
HTR1A P08908 2/20 0.58
HTR1B P28222 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9950019 0.90 ALDH1A1 (0.62) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL4490807 0.90 PPARG (0.71) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL6087947 0.89 HTR1D (0.60) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL10859130 0.88 LTA4H (0.67) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL30176255 0.86 LTA4H (0.64) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL853597 0.86 LTA4H (0.64) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL6088118 0.84 HTR1A (0.54) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL6219226 0.84 TRPM8 (0.70) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL2007192 0.83 TRPM8 (0.72) LTA4HPLA2G2AMEN1KMT2AHSP90AA1
SCHEMBL29007183 0.83 TRPM8 (0.76) LTA4HPLA2G2AMEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968272-B1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORP (US) 2021-06-16 EP disclosed
EP-2968272-B1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORP (US) 2021-06-16 EP disclosed
US-10653670-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening ALEVERE MEDICAL CORPORATION (US) 2020-05-19 US disclosed
US-10653670-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening ALEVERE MEDICAL CORPORATION (US) 2020-05-19 US disclosed
US-20190290613-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORPORATION 2019-09-26 US disclosed
US-20190290613-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORPORATION 2019-09-26 US disclosed
US-10258605-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening ALEVERE MEDICAL CORPORATION (US) 2019-04-16 US disclosed
US-10258605-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening ALEVERE MEDICAL CORPORATION (US) 2019-04-16 US disclosed
US-20180193309-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORPORATION 2018-07-12 US disclosed
US-20180193309-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING ALEVERE MEDICAL CORPORATION 2018-07-12 US disclosed
US-5525727-A ANALGESIC OR NARCOTIC ANTAGONIST UNIVERSITY OF FLORIDA (US) 1996-06-11 US disclosed
EP-0110955-B1 BRAIN-SPECIFIC DRUG DELIVERY UNIV FLORIDA (US) 1995-08-23 EP disclosed
US-5187158-A Sustained delivery of viricides UNIVERSITY OF FLORIDA (US) 1993-02-16 US disclosed
US-5008257-A Penicillin or cephalosporin antibiotics UNIVERSITY OF FLORIDA (US) 1991-04-16 US disclosed
US-4900837-A Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors UNIVERSITY OF FLORIDA (US) 1990-02-13 US disclosed
US-4880921-A Brain-specific drug delivery UNIVERSITY OF FLORIDA (US) 1989-11-14 US disclosed
US-4824850-A DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX CARRIER UNIVERSITY OF FLORIDA (US) 1989-04-25 US disclosed
US-4540564-A DIHYDROPYRIDINE AND/OR PYRIDINIUM SALT REDOX CARRIER UNIVERSITY OF FLORIDA (US) 1985-09-10 US disclosed
EP-0110955-A1 BRAIN-SPECIFIC DRUG DELIVERY. UNIV FLORIDA (US) 1984-06-20 EP disclosed
WO-1983003968-A1 BRAIN-SPECIFIC DRUG DELIVERY UNIVERSITY OF FLORIDA (US) 1983-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180193309-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING IDO1, FABP4, IDO2 LTA4H 753/4885PLA2G2A 1701/4885MEN1 3208/4885
US-20190290613-A1 USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING IDO1, FABP4, IDO2 LTA4H 753/4885PLA2G2A 1701/4885MEN1 3208/4885
US-10653670-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening IDO1, FABP4, IDO2 LTA4H 753/4885PLA2G2A 1701/4885MEN1 3208/4885
US-10258605-B2 Use of indole compounds for fat reduction and skin and soft tissue tightening IDO1, FABP4, IDO2 LTA4H 753/4885PLA2G2A 1701/4885MEN1 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.